Presentation TCT 2017 Flash Debate: FFR/iFR in ACS Patients With MVD - Based on the Evidence the Guidelines are Justified and Should Be Even Stronger! Presenter: Tim P. van de Hoef November 01, 2017 REGISTER for free or LOG IN to view this content Presentation TCT 2017 FFR Up Next Presentation TCT 2017 Flash Debate: FFR/iFR in ACS Patients With MVD There is Little Credible Evidence on Which to Base Any Recommendations! Presenter: Francesco Saia November 01, 2017 More slides + Presentation TCT 2017 Flash Debate: There Is Insufficient Evidence From Randomized Trials to Justify Frequent Use of Impella in High-Risk PCI and Cardiogenic Shock! Presenter: Holger Thiele November 01, 2017 Presentation TCT 2017 Flash Debate: Registry Data and Personal Experiences Are Strong Enough to Justify Frequent Use of IMPELLA in High-Risk PCI and Cardiogenic Shock! Presenter: Dimitri Karmpaliotis November 01, 2017 We Recommend
Presentation TCT 2017 Flash Debate: FFR/iFR in ACS Patients With MVD There is Little Credible Evidence on Which to Base Any Recommendations! Presenter: Francesco Saia November 01, 2017
Presentation TCT 2017 Flash Debate: There Is Insufficient Evidence From Randomized Trials to Justify Frequent Use of Impella in High-Risk PCI and Cardiogenic Shock! Presenter: Holger Thiele November 01, 2017
Presentation TCT 2017 Flash Debate: Registry Data and Personal Experiences Are Strong Enough to Justify Frequent Use of IMPELLA in High-Risk PCI and Cardiogenic Shock! Presenter: Dimitri Karmpaliotis November 01, 2017